Follow the Xuanzhu Biopharmaceutical Co., Ltd. - B - H Shares stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Market capitalisation: €594.6m. The latest transaction was reported on 18 May 2026 (Sale). Among the most active insiders: Li Jia Kui. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Xuanzhu Biopharmaceutical Co., Ltd. is a company focused on the development and manufacturing of biopharmaceutical products. It is listed under the B - H Shares category.